The thin line between non-inferiority clinical trials and type II errors ଝ

La delgada línea de ensayos clínicos de no inferioridad y el error tipo II
We welcome a randomized clinical trial (RCT) evaluating the sedation 1 strategies for low-risk patients requiring spinal anesthesia. 2 The authors conclude that there is no difference between groups except for higher withdrawal reflex and/or pain from puncture in the group that only received midazolam. In a purely academic spirit, we would like to underscore a few ideas.
Ideally, an RCT requires one person to administer the med-
ication and a second one to assess the outcomes. If this is not possible, the effect of the intervention may be overestimated (around 40%). 3 However, we empathize with those authors that sacrifice their own resources for the sake of science. 4 
The primary outcome variable -sample size calculation -
should be explicit. This is a usual issue with RCT. 5 3. When designing the essay: were the authors looking for the advantages of combination therapy versus the use of midazolam or on the contrary, were they looking for equivalence among interventions? -equivalence trials require hundreds and some times thousands of participants to avoid type II errors (assuming no difference when in fact there was a difference). 6 4. We don't want to look heartless, but would it be unreasonable to consider a placebo group (no sedation) or background music 7 for patients who just need a spinal injection?. . . sedation enhances the tolerance to the procedure but may deteriorate patient's cooperation for positioning.
